Prospects of Noncoding RNAs in Hepatocellular Carcinoma

BioMed Research International
Huaixiang ZhouLiu Yang

Abstract

Hepatocellular carcinoma (HCC) is a global health problem and one of the most common malignant tumors. Recent studies have shown that noncoding RNAs (ncRNAs) contribute to the pathogenesis of hepatocellular carcinoma (HCC). These RNAs may be involved in a variety of pathological processes such as cell proliferation, apoptosis, angiogenesis, invasion, and metastasis. In addition, abnormal expression of ncRNAs in HCC may provide potential prognostic or diagnostic biomarkers. This review provides an overview of the role and potential applications of ncRNAs, miRNAs, lncRNAs, circRNAs, and snoRNAs in liver cancer.

References

Dec 19, 2009·Proceedings of the National Academy of Sciences of the United States of America·Pascal PineauAnne Dejean
Jul 24, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Qinggong YuanAmar Deep Sharma
Feb 8, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Xin YangLun-Xiu Qin
Mar 22, 2014·Biomedical Reports·Jin-Hua HeYu-Guang Li
Jul 24, 2014·Biomedical Reports·Chunmei WangBo Bai
Aug 26, 2014·Expert Opinion on Therapeutic Targets·Jun ZhaoMatthew W Lawless
Aug 26, 2014·Clinics and Research in Hepatology and Gastroenterology·Wen-Yao WangLi-Chao Wang
Sep 15, 2014·Molecular Cancer·Gang XuZhong-Tian Qi
Nov 30, 2014·Virus Research·Cui-Ling DingWen Wang
May 15, 2015·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Chen LiLongbang Chen
Jul 18, 2015·World Journal of Gastroenterology : WJG·De-Fei HongYuan-Biao Zhang
Aug 21, 2015·World Journal of Gastroenterology : WJG·Rossella FarraBarbara Dapas
Sep 17, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ting ZhangLi Liu
Nov 19, 2015·Briefings in Functional Genomics·Anne-Susann Albrecht, Ulf Andersson Ørom
Nov 26, 2015·Cancer Biomarkers : Section a of Disease Markers·Meilin QinWenxin Qin
Dec 17, 2015·Clinics and Research in Hepatology and Gastroenterology·Chunbo ZhuangLihua Hu
May 3, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Min ZhangTao Yang
Jun 10, 2016·Oncology Reports·Wei JingJiancheng Tu
Oct 25, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Wei Peng, Hong Fan
Sep 12, 2016·Journal of Cancer Research and Clinical Oncology·Liangliang XuMingqing Xu
Oct 28, 2016·Biochemical and Biophysical Research Communications·Yunzhen GaoJingfeng Liu

❮ Previous
Next ❯

Citations

Dec 21, 2018·Molecular Medicine Reports·Qiong Yi, Wen-Jin Zou
Oct 12, 2019·Clinica Chimica Acta; International Journal of Clinical Chemistry·Dandan LiJinming Li
Mar 9, 2021·Frontiers in Genetics·Menglan WangJianxiang Chen
Sep 22, 2020·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Fen-Rong ChenLei Dong

❮ Previous
Next ❯

Methods Mentioned

BETA
acetylation

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.